
Sleep Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 106551 - 106551
Published: May 1, 2025
Language: Английский
Sleep Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 106551 - 106551
Published: May 1, 2025
Language: Английский
Sleep Medicine Reviews, Journal Year: 2023, Volume and Issue: 71, P. 101839 - 101839
Published: Aug. 22, 2023
Language: Английский
Citations
15Journal for Research in Applied Sciences and Biotechnology, Journal Year: 2023, Volume and Issue: 2(2), P. 14 - 26
Published: April 5, 2023
Although while getting a restful night's sleep is essential for your mental and physical health, insomnia very prevalent. More people are turning to complementary alternative therapies treat or prevent sleeplessness. For hundreds of years, herbal treatments like valerian, passionflower, lemon balm, lavender, California poppy have been utilized successfully. After using these medicines, latency was reduced subjective objective measures quality improved. Their sedative sleep-inducing effects caused by interactions with several neurotransmitter systems in the brain, according molecular research. The plant species can be divided into 76 different genera 32 families, Asteraceae (24.2%) Lamiaceae (21.1%) being most prevalent subgroups. Leaves (29%) flowers (27%), respectively, used make majority infusions (70%) decoctions (25%). Just well-known taxa—out 106 known—are treated here (A. arvensis L., C. nepeta monogyna Jacq., H. lupulus L. nobilis angustifolia Mill., M. sylvestris chamomilla officinalis O. basilicum P. rhoeas somniferum R. T. platyphyllus Scop., V. L.). Further study required confirm therapeutic potential substitutes define mechanism action bioactive compounds because only seven fifteen chosen investigated pharmacological activity as hypnotic-sedatives.
Language: Английский
Citations
14Journal of Psychiatric and Mental Health Nursing, Journal Year: 2024, Volume and Issue: 31(4), P. 654 - 667
Published: Jan. 16, 2024
Sleep problems are common among those with depression, and there is increasing evidence that sleep should be addressed during treatment simultaneously rather than treating depression alone. The first-line for insomnia cognitive behavioural therapy (CBT-I), due to a lack of well-trained therapists patient time constraints (travelling, work), CBT-I has not been popularized. development digital (dCBT-I) making the more accessible.
Language: Английский
Citations
5JMIR Mental Health, Journal Year: 2024, Volume and Issue: 11, P. e58217 - e58217
Published: June 15, 2024
Insomnia is a prevalent condition with significant health, societal, and economic impacts. Cognitive behavioral therapy for insomnia (CBTI) recommended as the first-line treatment. With limited accessibility to in-person-delivered CBTI (ipCBTI), electronically delivered eHealth (eCBTI), ranging from telephone- videoconference-delivered interventions fully automated web-based programs mobile apps, has emerged an alternative. However, relative efficacy of eCBTI compared ipCBTI not been conclusively determined.
Language: Английский
Citations
4Sleep Medicine, Journal Year: 2024, Volume and Issue: 122, P. 237 - 244
Published: Aug. 28, 2024
There is growing enthusiasm towards the role of smartphone app-based interventions in management insomnia and related sleep problems. A considerable number apps designed to address have been developed recent years, randomized controlled trials (RCTs) begun explore their efficacy. We conducted a meta-analysis investigating effectiveness for disturbances. From 19 RCTs, we identified significant pooled effect sizes primary outcomes self-reported (g = 0.60; 05 % CI 0.44, 0.76; NNT 4.8) disturbances 0.70; 95 0.58, 0.83; 4.1) favour over control conditions. These effects remained robust when restricting analyses that delivered placebo control, received lower risk bias rating, had larger sample size. Significant were also observed secondary night time awakenings 0.56), total 0.33), onset latency 0.32), but non-significant emerged daytime sleepiness, dysfunctional beliefs about sleep, efficiency, hygiene, wake after onset. The dropout rate from app conditions was 13.1 (95 8.3, 20.0), which significantly higher than (OR 1.78, 1.39, 2.28). Findings suggest stand-alone can effectively disturbances, may play an important these symptoms.
Language: Английский
Citations
4Sleep Medicine Reviews, Journal Year: 2022, Volume and Issue: 65, P. 101687 - 101687
Published: Aug. 12, 2022
Language: Английский
Citations
19Current Medical Research and Opinion, Journal Year: 2022, Volume and Issue: 38(10), P. 1727 - 1738
Published: Aug. 8, 2022
Objective The purpose of this study was to compare the effectiveness only Food and Drug Administration-authorized prescription digital therapeutic (PDT) Somryst versus face-to-face cognitive behavioral therapy for insomnia (CBT-I), or FDA-approved medications insomnia.Methods A systematic literature review undertaken identify relevant studies. Bayesian network meta-analysis (NMA) conducted examine (1) mean change in severity index (ISI); (2) proportional ISI remitters; (3) wake after sleep onset (WASO); (4) latency (SOL).Results Twenty studies provided data on PDT, CBT-I, CBT-I combination with self-help (SH), two (eszopiclone zolpidem). PDT associated significant (–5.77, 95% Credible Interval [CrI] − 8.53, −3.07) remitters (OR 12.33; CrI 2.28, 155.91) compared placebo, had highest probability being most effective treatment overall (56%), (64%). All evaluated interventions significantly outperformed placebo WASO but no differences were observed SOL (five interventions). Sensitivity analyses excluding meta-regression (assessing type, duration, delivery method CBT-I) did not affect NMA results.Conclusions This demonstrated that a delivering medications, as measured by reductions score from baseline ISI-determined remittance.
Language: Английский
Citations
17Journal of Sleep Research, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 31, 2025
Insomnia disorder, characterized by a complaint of reduced sleep quality or quantity and associated daytime impairment, is highly prevalent with life productivity. Cognitive behavioural therapy for insomnia (CBT-I) the current first-line treatment chronic disorder. Here, we outline our perspective future optimization psychotherapeutic insomnia. We identified following areas as most promising: first, optimizing efficacy CBT-I protocol; second, developing diagnostic therapeutic approaches non-responders partial responders; third, advancing widespread implementation psychotherapy More specifically, how protocol could be optimized through an improved understanding mechanisms, discuss potential adaptive strategies. Another promising approach improving using add-ons such physical exercise circadian-based interventions. Both may in certain subgroups patients In terms non-response, identify acceptance commitment (ACT-I) to CBT-I. ACT-I, however, still needs evaluated actual Implementing clinical practice one major challenges at hand. brief treatment, targeted challenging patient groups, digital help improve implementation. For research agenda, suggest that further into randomized-controlled trials CBT-I, focus on science have bring field forward.
Language: Английский
Citations
0Journal of Sleep Research, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 9, 2025
Sleep problems occur in up to 20%-45% of adolescents. This systematic review and meta-analysis examined the effectiveness digital sleep interventions, based on cognitive behavioural therapy for insomnia, adolescents with insomnia symptoms. The objective was synthesise quantify, through meta-analyses, changes following completion a sleep-based intervention. MEDLINE, PubMed, PsycINFO, Scopus, EMBASE, CENTRAL, Web Science databases were searched from January 2012 March 2024. Within-subject studies or randomized-controlled trials reporting effects included. Risk bias assessed using integrated quality criteria multiple study designs. Random-effects meta-analyses estimated pooled standardised within-subject mean differences assess effectiveness. Nine involving 486 Digital interventions effective reducing symptoms (Hedges' g = 1.40), subjective sleep-onset latency 0.72) waking after onset 0.47), increasing total time -0.29 -0.23, respectively). Other measures did not improve. All met minimum ICROMS score considered be sufficient quality. Seven failed satisfy all mandatory criteria. These results suggest that are improving adolescent's perceptions their sleep, but less at some sleep. To achieve clear understanding how compare other additional high-quality comparing traditional in-person modalities needed. (PROSPERO;CRD42021287479).
Language: Английский
Citations
0Sleep Medicine, Journal Year: 2025, Volume and Issue: 129, P. 219 - 237
Published: Feb. 22, 2025
Language: Английский
Citations
0